Showing results (201-210 of 777) with videos related to

Sort By:
Pageof 78
Blood|December 18, 2015
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cellsMichele Cea, Antonia Cagnetta, Sophia Adamia, et al.
Annals of Medicine|July 1, 2004
Proteasome inhibition in hematologic malignanciesPaul G Richardson, Teru Hideshima, Constantine Mitsiades, et al.
Blood|October 20, 2005
Antimyeloma activity of heat shock protein-90 inhibitionConstantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.
JCI Insight|February 8, 2023
Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myelomaJana Jakubikova, Danka Cholujova, Gabor Beke, et al.
Blood|January 17, 2013
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humansGüllü Topal Görgün, Gregory Whitehill, Jennifer L Anderson, et al.
Blood|September 18, 2012
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cellsZe Tian, Jian-jun Zhao, Yu-Tzu Tai, et al.
British Journal of Haematology|May 11, 2016
Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patientsNancy Levin, Andrew Spencer, Simon J Harrison, et al.
British Journal of Haematology|April 27, 2012
Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agentsMerav Leiba, Jana Jakubikova, Steffen Klippel, et al.
Leukemia|July 22, 2021
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myelomaJooeun Bae, Fabrizio Accardi, Teru Hideshima, et al.
Cancer Cell|September 15, 2012
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistanceDharminder Chauhan, Ze Tian, Benjamin Nicholson, et al.
Pageof 78